Parathyroid carcinoma in multiple endocrine neoplasia type 1 with a classic germline mutation

Endocrine Practice

Volumn 15, Issue 6, 2009, Pages 567-572

  Shih, Roger Y W ^a   Fackler, Sarah ^a   Maturo, Stephen ^a   True, Mark W ^a   Brennan, Joseph ^a   Wells, David ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; CHROMOGRANIN A; GASTRIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NORMETADRENALIN; PAMIDRONIC ACID; PARATHYROID HORMONE; SECRETIN; VITAMIN D;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; GASTRIN BLOOD LEVEL; GASTRINOMA; GENE MUTATION; GENETIC ANALYSIS; GERM LINE; HUMAN; HUMAN TISSUE; HYPOCALCEMIA; INTENSITY MODULATED RADIATION THERAPY; INTRAVENOUS ADMINISTRATION; MULTIPLE ENDOCRINE NEOPLASIA; NAUSEA; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARATHYROID CARCINOMA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PHOTON EMISSION TOMOGRAPHY; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; RADIATION DOSE; ADENOCARCINOMA; ADJUVANT THERAPY; GENETICS; HISPANIC; MIDDLE AGED; MUTATION; PARATHYROID TUMOR; PRIMARY HYPERPARATHYROIDISM; THYROIDECTOMY;

ADENOCARCINOMA; FEMALE; GASTRINOMA; GERM-LINE MUTATION; HISPANIC AMERICANS; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; RADIOTHERAPY, ADJUVANT; THYROIDECTOMY;

EID: 75549086316     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP09045.CRR1     Document Type: Article

References (20)

1. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86:5658-5671.
2. Gardner DG. Multiple endocrine neoplasia. In: Gardner DG, Shoback D, eds. Greenspan's Basic & Clinical Endocrinology. 8th ed. New York, NY: McGraw-Hill Companies Inc, 2004: 831.
3. Rizzoli R, Green J III, Marx SJ. Primary hyperparathyroidism in familial multiple endocrine neoplasia type I: long-term follow-up of serum calcium levels after parathyroidectomy. Am J Med. 1985;78:467-474.
4. Agha A, Carpenter R, Bhattacharaya S, Edmonson SJ, Carlsen E, Monson JP. Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognized entity. J Endocrinol Invest. 2007;30:145-149.
5. Obara T, Fujimoto Y. Diagnosis and treatment of patients with parathyroid carcinoma: an update and review. World J Surg. 1991;15:738-744.
6. Dionisi S, Minisola S, Pepe J, et al. Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis. Mayo Clin Proc. 2002;77:866-869.
7. Wilkinson S, Teh BT, Davey KR, McArdle JP, Young M, Shepherd JJ. Cause of death in multiple endocrine neoplasia type 1. Arch Surg. 1993;128:683-690.
8. Lambert LA, Shapiro SE, Lee JE, et al. Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Arch Surg. 2005;140:374-382.
9. Gibril F, Chen YJ, Schrump DS, et al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2003;88:1066-1081.
10. Teh BT. Thymic carcinoids in multiple endocrine neoplasia type 1. J Intern Med. 1998;243:501-504.
11. Perez-Monte JE, Brown ML, Clarke MR, Watson CG, Carty SE. Parathyroid hyperplasia, thymic carcinoid and pituitary adenoma detected with technetium-99m-MIBI in MEN type 1. J Nucl Med. 1997;38:1767-1769.
12. Shane E. Clinical review 122: parathyroid carcinoma. J Clin Endocrinol Metab. 2001;86:485-493.
13. Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA. Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine (Baltimore). 1992;71:197-205.
14. Rasmuson T, Kristoffersson A, Boquist L. Positive effect of radiotherapy and surgery on hormonally active pulmonary metastases of primary parathyroid carcinoma. Eur J Endocrinol. 2000;143:749-754.
15. Busaidy NL, Jimenez C, Habra MA, et al. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004;26: 716-726.
16. Munson ND, Foote RL, Northcutt RC, et al. Parathyroid carcinoma: is there a role for adjuvant radiation therapy? Cancer. 2003;98:2378-2384.
17. Yang Y, Hua X. In search of tumor suppressing functions of menin. Mol Cell Endocrinol. 2007;265-266:34-41.
18. Klein RD, Salih S, Bessoni J, Bale AE. Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory. Genet Med. 2005;7:131-138.
19. Sato M, Miyauchi A, Namihira H, et al. A newly recognized germline mutation of MEN1 gene identified in a patient with parathyroid adenoma and carcinoma. Endocrine. 2000;12:223-226.
20. Shattuck TM, Välimäki S, Obara T, et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med. 2003;349:1722-1729.